As of Apr 23
| -0.0154 / -0.26%|
The 4 analysts offering 12-month price forecasts for Apollo Endosurgery Inc have a median target of 10.25, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +75.68% increase from the last price of 5.83.
The current consensus among 4 polled investment analysts is to Buy stock in Apollo Endosurgery Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.